4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-18-018520
President and CEO sold 64,967 shares at an average $9.16 ($595,045)
- President and CEO acquired 54,503 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pomerantz Roger · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-25 | Exercise or conversion : show line 1 in the form | +16,288 | $0.71 | $11,564 | 255,056 | D |
| 2018-06-25 | Sale : show line 2 in the form | −26,752 | $9.21 | $246,504 | 228,304 | D |
| 2018-06-26 | Exercise or conversion : show line 3 in the form | +21,224 | $0.71 | $15,069 | 249,528 | D |
| 2018-06-26 | Sale : show line 4 in the form | −21,224 | $9.19 | $195,133 | 228,304 | D |
| 2018-06-27 | Exercise or conversion : show line 5 in the form | +16,991 | $0.71 | $12,064 | 245,295 | D |
| 2018-06-27 | Sale : show line 6 in the form | −16,991 | $9.03 | $153,408 | 228,304 | D |
| Open-market sales · 64,967 sh · avg $9.16 · $595,045 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-06-25 | Exercise or conversion : show line 7 in the form STOCK OPTION (RIGHT TO BUY) | −16,288 | $0.71 | 2024-08-07 | 16,288 | 895,153 | D |
| 2018-06-26 | Exercise or conversion : show line 8 in the form STOCK OPTION (RIGHT TO BUY) | −21,224 | $0.71 | 2024-08-07 | 21,224 | 873,929 | D |
| 2018-06-27 | Exercise or conversion : show line 9 in the form STOCK OPTION (RIGHT TO BUY) | −16,991 | $0.71 | 2024-08-07 | 16,991 | 856,938 | D |
Loading xslF345X03/doc4.xml…